Search for: "Novartis Pharmaceuticals Inc"
Results 301 - 320
of 394
Sort by Relevance
|
Sort by Date
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb) Trileptal (Oxacarbazepine) - Israel Patent Office prevents Novartis from submitting empirical evidence in patent opposition case (IP Factor) Vesicare (Solifenacin) – US: Astellas files patent infringement lawsuit against Teva over generic Vesicare (GenericsWeb) Zyprexa (Olanzapine) – Canada: Teva Novopharm invalidates Eli Lilly’s Canadian patent for Olanzapine (IP… [read post]
1 Oct 2009, 2:14 am
Novartis Pharmaceuticals Corp., 2007 WL 1521138 (D.N.J. [read post]
2 Sep 2009, 11:22 pm
Novartis Corp., 378 F. [read post]
2 Sep 2009, 5:57 pm
: Jacobson v Celgene (Patent Baristas) Ultracet (Tramadol/Acetaminophen) – US: CAFC vacates Ultracet obviousness decision: Ortho-McNeil Pharmaceutical, Inc v Teva Pharmaceuticals (not precedential) (Patently-O) (Patent Docs) (SmartBrief) Viread (Tenofovir) – India: MSF announces Patent Office rejected patents on AIDS drugs Tenofovir and Darunavir (Intellectual Property Watch) [read post]
17 Aug 2009, 8:01 am
For example, Teva has challenged and prevailed over Novartis, concerning the right to manufacture a generic copy of Lotrel, even though Novartis’ patent is valid until 2017. [read post]
17 Aug 2009, 8:01 am
For example, Teva has challenged and prevailed over Novartis, concerning the right to manufacture a generic copy of Lotrel, even though Novartis’ patent is valid until 2017. [read post]
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
6 Aug 2009, 6:50 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
20 Jul 2009, 2:00 pm
FDA And Health Canada Had Zelnorm Removed From Respective Markets In March 2007 Due To Concerns About Cardiovascular Safety (Posted by Tom Lamb at DrugInjuryWatch.com) In November 2008 a national class action was filed against Novartis Pharmaceuticals Canada Inc., seeking damages on behalf of all Canadians who ingested the medication Zelnorm (tegaserod) which was used by patients who had severe constipation or irritable… [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch)… [read post]
25 Jun 2009, 4:29 am
Novartis Pharmaceuticals Corp., 541 F. [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs) General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences (Managing… [read post]
7 May 2009, 6:08 am
Novartis Pharmaceuticals Corp., 252 F.3d 986, 990 (8th Cir. 2001); Hans v. [read post]
5 May 2009, 9:26 pm
District Court for the District of New Jersey denied Novartis Pharmaceutical Corp.'s request for a jury trial in its suit against Roxane Laboratories Inc. [read post]
21 Apr 2009, 8:45 am
Ortho-McNeil, Inc., No. [read post]
